GSK Operating Income 2010-2022 | GSK

GSK annual/quarterly operating income history and growth rate from 2010 to 2022. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  • GSK operating income for the quarter ending September 30, 2022 was $1.403B, a 47.51% decline year-over-year.
  • GSK operating income for the twelve months ending September 30, 2022 was $7.697B, a 12.78% decline year-over-year.
  • GSK annual operating income for 2021 was $8.527B, a 14.67% decline from 2020.
  • GSK annual operating income for 2020 was $9.993B, a 12.43% increase from 2019.
  • GSK annual operating income for 2019 was $8.889B, a 21.45% increase from 2018.
GSK Annual Operating Income
(Millions of US $)
2021 $8,527
2020 $9,993
2019 $8,889
2018 $7,319
2017 $5,267
2016 $3,521
2015 $15,782
2014 $5,417
2013 $10,392
2012 $11,717
2011 $12,526
2010 $5,850
2009 $13,193
GSK Quarterly Operating Income
(Millions of US $)
2022-09-30 $1,403
2022-06-30 $1,357
2022-03-31 $3,758
2021-12-31 $1,179
2021-09-30 $2,672
2021-06-30 $2,341
2021-03-31 $2,335
2020-12-31 $1,477
2020-09-30 $2,400
2020-06-30 $3,537
2020-03-31 $2,580
2019-12-31 $2,473
2019-09-30 $2,647
2019-06-30 $1,908
2019-03-31 $1,860
2018-12-31 $1,368
2018-09-30 $2,489
2018-06-30 $1,060
2018-03-31 $2,401
2017-12-31 $707
2017-09-30 $2,457
2017-06-30 $-26
2017-03-31 $2,128
2016-12-31 $740
2016-09-30 $1,879
2016-06-30 $-217
2016-03-31 $1,036
2015-12-31 $13,361
2015-09-30 $1,434
2015-06-30 $420
2015-03-31 $636
2014-12-31 $-57
2014-09-30 $1,358
2014-06-30 $1,754
2014-03-31 $1,798
2013-12-31 $3,669
2013-09-30 $2,714
2013-06-30 $2,159
2013-03-31 $2,168
2012-12-31 $3,566
2012-09-30 $2,853
2012-06-30 $2,621
2012-03-31 $3,002
2011-12-31 $3,723
2011-09-30 $3,115
2011-06-30 $2,783
2011-03-31 $2,752
2010-12-31 $-270
2010-09-30 $3,036
2010-06-30 $-1,208
2010-03-31 $3,068
2009-12-31 $4,080
2009-09-30 $3,402
2009-06-30 $3,480
2009-03-31 $2,384
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $68.515B $46.910B
GSK plc is a biopharma company. Its vaccine portfolio protects people from meningitis, shingles, flu, polio, measles and many more. GSK plc, formerly known as GLAXOSMITHKLINE, is based in Brentford, the United Kingdom.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $168.264B 10.27
Bio-Rad Laboratories (BIO.B) United States $11.666B 27.68
QIAGEN (QGEN) Netherlands $11.104B 18.95
Ginkgo Bioworks Holdings (DNA) United States $3.534B 0.00
Myovant Sciences (MYOV) United Kingdom $2.599B 0.00
Arcus Biosciences (RCUS) United States $1.967B 29.53
Biohaven (BHVN) United States $1.050B 0.00
Emergent Biosolutions (EBS) United States $0.590B 4.64
Zymeworks (ZYME) Canada $0.506B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.282B 0.00
Enzo Biochem (ENZ) United States $0.096B 0.00
SQZ Biotechnologies (SQZ) United States $0.077B 0.00
Gelesis Holdings (GLS) United States $0.030B 0.00
Ambrx Biopharma (AMAM) United States $0.019B 0.00